Tech Company Financing Transactions

Xencor Funding Round

MedImmune Ventures, HealthCare Ventures and Novo Ventures joined a $45 million capital raise for Xencor. This venture round was announced on 10/23/2006.

Transaction Overview

Company Name
Xencor
Announced On
10/23/2006
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Undisclosed
Investors

MedImmune Ventures (Lead Investor) (Wayne Hockmeyer)

HealthCare Ventures (Gus Lawler)

Novo Ventures (Esper Boel)

Proceeds Purpose
The financing, which includes an initial $6 million bridge financing that the company announced in July, will be used to advance the clinical development of two biologic drug compounds, a first-in-class protein therapeutic and a novel antibody drug candidate. Both were developed using the company's Protein Design Automation® (PDA®) technologies. To date, Xencor has raised $130 million in financing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
111 West Lemon Ave.
Monrovia, CA 91016
USA
Phone
(626) 305-5900
Website
www.xencor.com
Email Address
[email protected]
Overview
In collaboration with our partners -- including leading biotechnology company Genentech and pharmaceutical company Eli Lilly -- we are selectively designing next-generation protein drug candidates with improved selectivity, efficacy and safety.
Profile
Xencor LinkedIn Company Profile
Social Media
Xencor Company Twitter Account
Company News
Xencor News
Facebook
Xencor on Facebook
YouTube
Xencor on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bassil Dahiyat
  Bassil Dahiyat LinkedIn Profile  Bassil Dahiyat Twitter Account  Bassil Dahiyat News  Bassil Dahiyat on Facebook
Chief Medical Officer
Paul Foster
  Paul Foster LinkedIn Profile  Paul Foster Twitter Account  Paul Foster News  Paul Foster on Facebook
VP - Finance
John Kuch
  John Kuch LinkedIn Profile  John Kuch Twitter Account  John Kuch News  John Kuch on Facebook
VP - R & D
John Desjarlais
  John Desjarlais LinkedIn Profile  John Desjarlais Twitter Account  John Desjarlais News  John Desjarlais on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/23/2006: Free 411 venture capital transaction
Next: 10/23/2006: Neocase Software venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.